CVRx (CVRX) Cash from Financing Activities (2020 - 2026)
CVRx (CVRX) posted Cash from Financing Activities of $1.2 million for Q2 2026, down 86.25% on a QoQ basis from $8.9 million in Q1 2026, and up 211.48% year-over-year from $392000.0 in Q2 2025.
Analysis
CVRx (CVRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends
CVRx has reported Cash from Financing Activities for 7 years, with the latest figure at $1.2 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 211.48% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $10.6 million, a 83.42% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 81.17% from the prior year.
- Cash from Financing Activities was $1.2 million for Q2 2026 at CVRx, down from $8.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $40.2 million in Q3 2024, with the low at $7000.0 in Q3 2022.
- Average Cash from Financing Activities over 5 years is $6.0 million, with a median of $847000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 99.99% in 2022, then soared 15666.67% in 2023.
- Over 5 years, Cash from Financing Activities stood at $7.1 million in 2022, then jumped by 118.91% to $15.6 million in 2023, then decreased by 11.21% to $13.8 million in 2024, then sank by 97.04% to $410000.0 in 2025, then jumped by 197.8% to $1.2 million in 2026.
- The last three Cash from Financing Activities figures came in at $1.2 million (Q2 2026), $8.9 million (Q1 2026), and $410000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | CVRx | 81.26 Mn | 16.67 Mn | 13.72 Mn | 1.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 15.58 Mn |
| Sep 30, 2023 | 363,000.00 |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 7.57 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 321,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Dec 31, 2021 | -21.29 Mn |
| Sep 30, 2021 | 133.17 Mn |